查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927375

週边旋转动脉粥状硬化斑块切除术市场按产品类型、索赔类型、应用和最终用户划分 - 全球预测 2026-2032 年

Peripheral Rotational Atherectomy Market by Product Type, Claim Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年外周旋转动脉动脉粥状硬化斑块切除术市场价值为 9.8568 亿美元，预计到 2026 年将增长至 10.5878 亿美元，年复合增长率为 8.28%，到 2032 年将达到 17.2068 亿美元。

关键市场统计数据
基准年 2025 9.8568亿美元
预计年份：2026年 1,058,780,000 美元
预测年份 2032 17.2068亿美元
复合年增长率 (%) 8.28%

週边动脉粥状硬化斑块切除术的临床需求、技术成熟度、手术流程和相关人员动机概述

週边旋转动脉粥状硬化斑块切除术是一种针对钙化性周边动脉疾病的介入治疗技术，其当代意义在于临床、技术和操作因素的交会点。临床医师日益面临膝下和髂股动脉区域复杂病变形态的挑战，促使人们重新关注能够在修復钙化斑块的同时，保留远端灌注和肢体挽救潜力的工具。同时，器械的成熟也拓展了临床医生的选择范围，并推动了手术流程的改进，使其能够整合混合策略、辅助影像学检查以及高风险患者的分期重组。

临床路径、器材创新、报销理念和竞争动态的变革性转变重塑了周边动脉粥状硬化斑块切除术

週边血管动脉粥状硬化斑块切除术的格局正因多项变革而重塑，这些变革融合了临床洞见、器械创新和医保支付方的期望。在手术操作方面，辅助影像技术和血管准备策略的整合已取得显着进展，从而降低了手术操作的变异性，并改善了病变特异性治疗方案的发展。这种转变提升了那些能够实现可预测的斑块修饰、最大限度减少下游栓塞，并针对不同病变形态提供独特效用的器械的价值。

2025年美国关税调整对供应链、设备成本、筹资策略及全球采购的累积影响

美国关税调整将于2025年生效，其累积影响正为全球週边介入器材供应链带来新的复杂性，并影响采购、成本结构和筹资策略。拥有跨境业务的製造商和经销商被迫重新评估其零件采购、合约条款和库存管理政策，以缓解不断增加的成本压力。为此，一些供应商正在加快对替代供应商的资格认证，推广本地组装，并调整产品组合，以在保持临床性能标准的同时，维持价格竞争力。

透过整合产品类型、临床应用、终端使用者画像和支付方理赔类别等因素进行高价值細項分析，指南策略定位

细緻的细分方法揭示了产品差异、临床适应症、临床环境和支付方路径如何相互作用，从而决定週边动脉粥状硬化斑块切除术的应用特征和价值概况。产品细分区分了动脉粥状硬化斑块切除术导管（进一步分为高剖面导管和Low profile导管）和动脉粥状硬化斑块切除术系统（包括主机和可携式系统）。这种区分会影响操作者的偏好、库存计划以及根据病变类型进行的临床应用。应用细分区分了针对胫动脉和腓动脉的膝下介入治疗以及髂股动脉介入治疗。每种临床环境都有其独特的入路、影像和辅助性治疗的考虑因素，这些因素都会影响器械的选择。

影响临床应用的区域趋势和采用模式（美洲、欧洲、中东和非洲、亚太地区）

区域趋势在决定週边血管动脉粥状硬化斑块切除术的进入、应用和商业策略方面发挥关键作用。在美洲，报销框架和一体化的医疗保健系统通常能够促进协调的治疗路径开发，从而在临床获益得到证实的情况下支持技术的应用；同时，成本控制的压力也要求提供明确的疗效改善证据。在欧洲、中东和非洲，不同的管理体制和不均衡的支付结构使得制定量身定制的市场参与策略成为必要。製造商和临床领导者通常依靠区域卓越中心和本地证据来支持技术的广泛应用。在亚太地区，公私合作的资金筹措模式，加上介入治疗服务能力的快速发展，既带来了机会，也带来了竞争，尤其是在那些週边血管计画和肢体挽救倡议投资不断增加的地区。

竞争与合作并存的企业趋势：主要企业的产品系列与策略措施塑造了其竞争优势

关键的企业趋势正在塑造外周旋动脉粥状硬化斑块切除术的竞争定位和创新路线。器械製造商与临床网路之间的策略联盟加速了实证医学证据的积累，并透过整合培训、上市后监测和疗效基准，为更广泛的应用铺平了道路。同时，有针对性的收购和产品组合重组使一些公司能够透过将器械平台与止血、成像和导管技术相结合，从而提升临床疗效，进而拓展其价值提案。

针对医疗设备製造商、临床领导者和支付者的具体建议：加速临床应用、优化供应链韧性、改善病患预后

产业领导者应优先采取一系列协作行动，将洞见转化为临床和商业性绩效的可衡量改善。首先，製造商和医院合作伙伴需要投资于有针对性的临床医生教育和操作指导，以减少操作者之间的差异，并加速在各种病变类型中安全、一致地应用相关技术。此外，制定共用的通讯协定和结果指标，可以使手术团队、护理人员和管理人员围绕通用的品质目标达成一致，并更清晰地评估器械对併发症发生率和住院时间的影响。

全面透明的调查方法详细说明了资料来源、相关人员参与、分析框架和检验方法。

本分析基于多源调查方法，旨在确保透明度、可重复性和对临床及商业决策者的相关性。主要资料来源包括对介入医师、器材采购人员和支付方代表的结构化访谈，以收集第一线经验和关键采购挑战。二级资讯来源包括同侪审查的临床文献、监管申报文件和操作指南文件，以检验临床表现特征和安全性概况。数据综合根据一个主题框架进行，该框架将临床适应症、医疗设备特性和操作限制联繫起来。

为相关相关人员提供一份简明扼要、重点突出的策略意义、临床优先事项和后续操作步骤概述。

总之，週边血管动脉粥状硬化斑块切除术的策略意义不仅限于器械选择，还涵盖临床路径设计、供应链韧性以及多方相关人员的协作。相关人员仅关注器械性能而忽略培训、报销和库存动态等问题，则可能导致推广速度缓慢，疗效欠佳。相反，对临床医师教育、实证医学证据产生和适应性采购模式进行协调投资，既能加快推广速度，又能保障临床品质和财务责任。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 週边旋转动脉动脉粥状硬化斑块切除术市场（依产品类型划分）

  • 旋切动脉粥状硬化斑块切除术
    • 高位导尿管
    • Low profile导管
  • 旋转动脉粥状动脉粥状硬化斑块切除术系统
    • 主机系统
    • 可携式系统

9. 依索赔类型分類的周边旋转动脉粥状硬化斑块切除术市场

  • 政府保险
    • 医疗补助
    • 联邦医疗保险
  • 自费
  • 私人保险
    • HMO
    • 产物保险
    • PPO

第十章 依应用分類的周边旋转动脉动脉粥状硬化斑块切除术市场

  • 膝盖以下
    • 腓动脉
    • 胫骨
  • 髂股动脉

第十一章 外周旋转动脉粥样斑块动脉粥状硬化斑块切除术市场（按最终用户划分）

  • 门诊手术中心
    • 独立中心
    • 医院所属中心
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所

12. 週边旋转动脉粥状斑块动脉粥状硬化斑块切除术市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 週边旋转动脉粥状斑块动脉粥状硬化斑块切除术市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国週边血管旋转动脉粥状斑块动脉粥状硬化斑块切除术市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国週边血管旋转动脉动脉粥状硬化斑块切除术市场

第十六章 中国週边血管旋转动脉粥状斑块动脉粥状硬化斑块切除术市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Avinger, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc
  • Cook Medical LLC
  • INVAMED
  • Koninklijke Philips NV
  • Medtronic PLC
  • NEScientific, Inc
  • NIPRO CORPORATION
  • RA Medical Systems, Inc.
  • Rotarex, SA by Becton, Dickinson and Company
  • Straub Medical AG
Product Code: MRR-4F7A6D4FF383

The Peripheral Rotational Atherectomy Market was valued at USD 985.68 million in 2025 and is projected to grow to USD 1,058.78 million in 2026, with a CAGR of 8.28%, reaching USD 1,720.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 985.68 million
Estimated Year [2026] USD 1,058.78 million
Forecast Year [2032] USD 1,720.68 million
CAGR (%) 8.28%

Introductory framing of clinical need technology maturation procedural workflows and stakeholder motivations that define peripheral rotational atherectomy

Peripheral rotational atherectomy represents a focused interventional capability for treating calcified peripheral arterial disease, and its contemporary relevance rests on intersecting clinical, technological, and operational drivers. Clinicians increasingly confront complex lesion morphology in below-knee and iliofemoral territories, prompting renewed attention to tools that can modify calcified plaque while preserving distal perfusion and limb salvage potential. Concurrently, device maturation has expanded options for practitioners, with procedural workflows evolving to incorporate hybrid strategies, adjunctive imaging, and staged revascularization in higher-risk patients.

From an operational perspective, institutions and ambulatory care sites are balancing the imperative to reduce length-of-stay and procedural complications against the need to maintain high-quality outcomes. As a result, clinical teams and procurement leaders are revisiting vendor selection criteria, lifecycle costs, and training commitments to ensure that adoption of ablative technologies translates into measurable improvements in patient throughput and complication avoidance. Taken together, these forces create a context in which strategic choices about product selection, pathway integration, and stakeholder alignment determine whether peripheral rotational atherectomy achieves durable adoption in contemporary practice.

Transformational shifts in clinical pathways device innovation reimbursement ethos and competitive dynamics reshaping peripheral rotational atherectomy

The landscape for peripheral rotational atherectomy is being reshaped by several transformative shifts that combine clinical insights, device innovation, and payer expectations. Procedurally, there is a visible movement toward integrating adjunctive imaging and vessel preparation strategies that reduce procedural variability and improve lesion-specific planning. This shift amplifies the value of devices that offer predictable plaque modification with minimal downstream embolization and clear utility across a range of lesion morphologies.

On the technology front, incremental improvements in catheter profiles, burr design, and system ergonomics are enabling broader operator comfort and more consistent performance in challenging anatomies. At the same time, the competitive environment has driven manufacturers to emphasize service models, training programs, and bundled offerings that align commercial terms with value-based outcomes. Reimbursement landscapes and hospital procurement priorities are also evolving; decision-makers increasingly require evidence linking device choice to reduced complications and downstream resource utilization. Together, these trends are converging to push peripheral rotational atherectomy from a niche specialty technique toward a more standardized component of complex limb salvage pathways, provided stakeholders coordinate training, supply, and clinical governance effectively.

Cumulative implications of United States tariff adjustments effective in 2025 on supply chains device costs procurement strategies and global sourcing

The cumulative impact of United States tariff adjustments implemented in 2025 has introduced new complexities to global supply chains for peripheral interventional devices, affecting procurement, cost structures, and sourcing strategies. Manufacturers and distributors operating across borders have had to re-evaluate component sourcing, contract terms, and inventory policies to mitigate incremental cost pressures. In response, some suppliers have accelerated qualification of alternative suppliers, localized assembly, or adjusted product configurations to preserve price competitiveness while maintaining clinical performance standards.

Procurement teams and hospital systems have likewise adapted purchasing strategies to respond to higher landed costs and greater supply volatility. Longer-term supply agreements, strategic inventory buffering, and closer collaboration with manufacturers on consignment or managed inventory models have emerged as pragmatic responses. Importantly, clinical teams and device leadership have emphasized the need to avoid compromising clinical choice; thus, value discussions have shifted from unit price alone to total cost of care, including procedure efficiency, complication avoidance, and readmission prevention. Looking forward, the tariff-driven pressures have catalyzed stronger cross-functional alignment among sourcing, clinical, and commercial teams to preserve access to essential technologies while managing fiscal accountability.

High-value segmentation insights integrating product types clinical applications end-user profiles and payer claim categories to inform strategic positioning

A nuanced segmentation approach reveals how product variants, clinical indications, care settings, and payer pathways interact to define distinct adoption and value profiles for peripheral rotational atherectomy. Product segmentation differentiates Rotational Atherectomy Catheters, which are further characterized by High Profile Catheters and Low Profile Catheters, from Rotational Atherectomy Systems, which comprise Console Systems and Portable Systems; this delineation affects operator preference, inventory planning, and clinical application across lesion types. Application segmentation distinguishes Below Knee interventions-including targeted Peroneal and Tibial procedures-from Iliofemoral interventions, with each clinical context presenting unique access, imaging, and adjunctive therapy considerations that influence device selection.

End-user segmentation captures the operational diversity of Ambulatory Surgery Centers, Hospitals, and Specialized Clinics. Ambulatory Surgery Centers are subdivided into Free Standing Centers and Hospital Owned Centers, while Hospitals are classified into Private Hospitals and Public Hospitals; these distinctions shape procurement cycles, training investments, and volume-driven economics. Finally, claim type segmentation illustrates how reimbursement pathways affect adoption, contrasting Government Insurance, broken down into Medicaid and Medicare, with Private Insurance arrangements including HMO, Indemnity Insurance, and PPO, and the role of Out Of Pocket payment. Together, these interlocking segments provide a framework for prioritizing clinical evidence generation, tailoring commercial propositions, and designing differentiated service models that align with the operational realities of each stakeholder group.

Region-specific dynamics and adoption patterns across the Americas Europe Middle East & Africa and Asia-Pacific that influence clinical access

Regional dynamics play an outsized role in determining access, uptake, and commercial strategy for peripheral rotational atherectomy. In the Americas, reimbursement frameworks and integrated health systems often enable coordinated pathway development that supports technology adoption when clinical benefit is demonstrable, but cost containment pressures demand clear evidence of improved outcomes. In Europe, Middle East & Africa, diverse regulatory regimes and heterogeneous payer architectures require tailored entry strategies; manufacturers and clinical champions often rely on regional centers of excellence and localized evidence to support broader adoption. In Asia-Pacific, mixed public-private funding models combine with rapid capacity expansion in interventional services to create both opportunities and competition, particularly where investments in peripheral vascular programs and limb salvage initiatives are expanding.

These geographic differences influence regulatory timelines, required evidence packages, and the structure of commercial partnerships. For example, product configurations and training programs that succeed in high-volume tertiary centers in one region may require adaptation for ambulatory or community-based settings elsewhere. Consequently, cross-regional learning and adaptive commercialization-where insights from one geography inform clinical education and value articulation in another-become important mechanisms to accelerate appropriate, sustainable adoption while respecting local reimbursement and regulatory realities.

Competitive and collaborative corporate developments product portfolios and strategic moves by key companies shaping competitive advantage

Key corporate developments are shaping competitive positioning and the innovation pipeline for peripheral rotational atherectomy. Strategic collaborations between device manufacturers and clinical networks have accelerated evidence generation and created pathways for broader adoption by aligning training, post-market surveillance, and outcome benchmarking. At the same time, targeted acquisitions and portfolio realignments have enabled some firms to extend their value propositions by combining device platforms with hemostasis, imaging, or catheter technologies that augment clinical efficacy.

Product portfolio strategies now emphasize not only device performance but also service elements such as training, proctoring, and data-driven outcome support. Companies that invest in clinician education, robust clinical registries, and integrated consignment or inventory solutions tend to see stronger alignment with hospital procurement committees. Moreover, firms that can demonstrate iterative product improvements while maintaining supply reliability and competitive commercial structures secure preferential consideration among health systems. Ultimately, competitive advantage is increasingly derived from the ability to offer a holistic solution that pairs device efficacy with operational support, clinical validation, and flexible contracting models.

Actionable recommendations for device manufacturers clinical leaders and payers to accelerate clinical adoption optimize supply resilience and improve patient

Industry leaders should prioritize a set of coordinated actions to translate insights into measurable improvements in clinical and commercial performance. First, manufacturers and hospital partners must invest in targeted clinician education and procedural proctoring to reduce operator variability and accelerate safe, consistent adoption across diverse lesion types. Complementary to this, creating shared protocols and outcome metrics can align surgical teams, nursing staff, and administrators around common quality goals, enabling clearer evaluation of device impact on complication rates and lengths of stay.

Second, supply resilience must be strengthened through diversified sourcing, strategic inventory policies, and collaborative commercial models such as consignment or vendor-managed inventory. These approaches mitigate near-term disruption while preserving clinician access to preferred device configurations. Third, payers and procurement teams should be engaged early with robust clinical evidence that links device selection to downstream cost avoidance and improved limb salvage; value-based contracting pilots can provide practical proof points. Finally, organizations should adopt iterative post-market surveillance and real-world evidence collection to inform iterative product improvements, support reimbursement dialogues, and sustain clinician confidence. Taken together, these actions create a pragmatic roadmap for stakeholders seeking to expand access while safeguarding quality and fiscal stewardship.

Comprehensive and transparent research methodology detailing data sources stakeholder engagements analytical frameworks and validation approaches

This analysis is grounded in a multi-source methodology designed to ensure transparency, reproducibility, and relevance to clinical and commercial decision-makers. Primary inputs included structured interviews with interventional specialists, device procurement leads, and payer representatives to capture frontline experiences and procurement imperatives. Secondary sources comprised peer-reviewed clinical literature, regulatory filings, and procedural guidance documents to verify clinical performance characteristics and safety profiles. Data synthesis followed a thematic framework that aligned clinical indications, device attributes, and operational constraints.

Analytical methods combined qualitative synthesis with cross-validation techniques to ensure that assertions about clinical utility, adoption barriers, and supply chain dynamics were corroborated across multiple sources. Validation approaches included expert review panels and scenario testing with clinician partners to ensure practical applicability. Where gaps in evidence were identified, the research prioritized triangulation through additional interviews and focused literature review. The result is a methodology that balances rigour with field relevance, producing insights that are actionable for product strategy, clinical engagement, and supply chain planning.

Concise but conclusive closing synthesis of strategic implications clinical priorities and operational next steps for stakeholders engaged

In closing, the strategic implications of peripheral rotational atherectomy extend beyond device selection to encompass clinical pathway design, supply chain resilience, and multi-stakeholder alignment. Stakeholders that focus solely on device performance without addressing training, reimbursement, and inventory dynamics risk slower adoption and suboptimal outcomes. Conversely, coordinated investments in clinician education, evidence generation, and adaptive procurement models can accelerate adoption while protecting clinical quality and fiscal responsibility.

Operationally, the path forward emphasizes cross-functional governance that unites clinical champions, procurement leaders, and payer relations teams. Clinically, sustained focus on outcome measurement and iterative practice improvement will be essential to demonstrate value. Taken together, these priorities form a pragmatic blueprint for institutions and manufacturers committed to expanding access to advanced peripheral interventions while ensuring that adoption translates into improved patient-centered outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Rotational Atherectomy Market, by Product Type

  • 8.1. Rotational Atherectomy Catheters
    • 8.1.1. High Profile Catheters
    • 8.1.2. Low Profile Catheters
  • 8.2. Rotational Atherectomy Systems
    • 8.2.1. Console Systems
    • 8.2.2. Portable Systems

9. Peripheral Rotational Atherectomy Market, by Claim Type

  • 9.1. Government Insurance
    • 9.1.1. Medicaid
    • 9.1.2. Medicare
  • 9.2. Out Of Pocket
  • 9.3. Private Insurance
    • 9.3.1. Hmo
    • 9.3.2. Indemnity Insurance
    • 9.3.3. Ppo

10. Peripheral Rotational Atherectomy Market, by Application

  • 10.1. Below Knee
    • 10.1.1. Peroneal
    • 10.1.2. Tibial
  • 10.2. Iliofemoral

11. Peripheral Rotational Atherectomy Market, by End User

  • 11.1. Ambulatory Surgery Centers
    • 11.1.1. Free Standing Centers
    • 11.1.2. Hospital Owned Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals
  • 11.3. Specialized Clinics

12. Peripheral Rotational Atherectomy Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peripheral Rotational Atherectomy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peripheral Rotational Atherectomy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Peripheral Rotational Atherectomy Market

16. China Peripheral Rotational Atherectomy Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Avinger, Inc.
  • 17.6. B. Braun SE
  • 17.7. Boston Scientific Corporation
  • 17.8. Cardiovascular Systems, Inc
  • 17.9. Cook Medical LLC
  • 17.10. INVAMED
  • 17.11. Koninklijke Philips N.V.
  • 17.12. Medtronic PLC
  • 17.13. NEScientific, Inc
  • 17.14. NIPRO CORPORATION
  • 17.15. RA Medical Systems, Inc.
  • 17.16. Rotarex, SA by Becton, Dickinson and Company
  • 17.17. Straub Medical AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HIGH PROFILE CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HIGH PROFILE CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HIGH PROFILE CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY LOW PROFILE CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY LOW PROFILE CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY LOW PROFILE CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CONSOLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CONSOLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CONSOLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICAID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICAID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICAID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY OUT OF POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY OUT OF POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY OUT OF POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDEMNITY INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDEMNITY INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDEMNITY INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PPO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PPO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PPO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PERONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PERONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PERONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY TIBIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY TIBIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY TIBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ILIOFEMORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ILIOFEMORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ILIOFEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY FREE STANDING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY FREE STANDING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY FREE STANDING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SPECIALIZED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SPECIALIZED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 202. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)